Search

everythinglearnresearchcommunity

for

Search:↓

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Systemic lupus erythematosus is diagnosed earlier in males than females.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Early recognition and a multidisciplinary approach are crucial for effectively managing complex autoimmune conditions like SLE with CAPS and AHA.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Biologics for severe asthma have known side effects, but some new risks need more study.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Cultured dermal papilla cells can regenerate hair follicles and sustain hair growth.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.

Placental extracts have antioxidant, anti-inflammatory, and immune-boosting effects, but their exact workings are unclear.

Upadacitinib improved multiple immune-related conditions in one patient.

Nanoparticle systems make cancer treatment less toxic.

Silver nanoparticles in gel form can effectively heal wounds.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Adults with certain skin conditions may have higher levels of inflammation in their body.

High glucocorticoids cause pancreatic malfunction and malabsorption, reversible with enzyme supplements.